Introduction
Despite recent advances in therapeutic modalities, colorectal cancer (CRC) remains 2 one of the most common causes of cancer-related death in developed countries (1) . 3 Currently, chemoprevention for CRC has attracted much attention. The purpose of 4 chemoprevention is to reduce the future mortality of CRC using oral agents that can 5 prevent the occurrence of cancer. Although the occurrence of CRC is the most reliable 6 endpoint, such an endpoint is unsuitable for chemoprevention trials because the 7 occurrence of CRC in the general population is relatively infrequent (1) and such trials 8 would require long-term observation periods. Therefore, to evaluate the efficacy of 9 chemopreventive agents in CRC chemoprevention trials, a more common surrogate animal models of chemical colonic carcinogenesis. Importantly, many agents that block 1 ACF growth were also shown to prevent tumor development in these carcinogen-treated 2 rodent models (11). Thus, in rodent models, ACF have been established as a precursor 3 of CRC. Shortly after such descriptions in rodent models were made, ACF were 4 discovered in pathologic specimens of human colonic mucosa (12) (13) (14) . ACF were 5 subsequently identified in the colonic mucosa in vivo using high-magnification 6 chromoscopic colonoscopy (HMCC) with methylene blue staining (15). Although 7 several previous epidemiological studies have revealed significant associations between 8 the prevalence and/or number of ACF and the synchronous presence of advanced 9 neoplasms, including both adenoma and CRC (15-22), most of the sample sizes in these 10 studies were relatively small. Consequently, the findings were somewhat conflicting. In 11 addition, these studies had limited data regarding other personal characteristics, such as association between the presence of ACF and the adenoma history. The correlations 1 between the demographic and behavioral characteristics in relation to colorectal 2 carcinogenesis and the prevalence and number of ACF were also assessed. Our results 3 may help to further evaluations of the potential utility of ACF as a surrogate biomarker 4 for CRC. The study protocol was approved by the Yokohama City University Hospital Ethics 9 Committee. Between 2004 and 2009, we enrolled 861 subjects who underwent 10 diagnostic endoscopy at the Yokohama City University Hospital, Japan: of the 861 11 subjects, 383 had no apparent lesions of the colorectum on colonoscopy (normal including smoking habit, alcohol habit and body mass index (BMI), were obtained from 1 the subjects prior to the performance of the colonoscopy. High-magnification chromoscopic colonoscopy 3 A Fujinon EC-490ZW5/M colonoscope was used for the magnifying colonoscopy 4 (Fujinon Toshiba ES Systems Co., Ltd, Tokyo, Japan). All the subjects were subjected to 5 bowel preparation using a polyethylene glycol-based solution, and underwent a total 6 colonoscopy prior to rectal ACF imaging. Any detected adenomas were biopsied and the 7 histopathological appearance was analyzed. Advanced adenoma was defined as an 8 adenoma lesion measuring 1 cm or greater in diameter and/or exhibiting a villous 9 histology and/or high-grade dysplasia. Subsequently, 0.25% methylene blue was applied 10 to the mucosa using a spray catheter. Based on the results of a previous study, the ACF 11 were counted in the lower rectal region, from the middle Houston valve to the dentate 12 line (15). To guard against double counting, the ACF were counted in a sequential 13 fashion during a single withdrawal of the endoscope. We evaluated the presence of ACF 14 and the category of the subject (normal subjects, adenoma cases, and CRC cases) 15 simultaneously.
16
Criteria used for the endoscopic diagnosis 17 ACF were defined as lesions in which the crypts were larger in diameter and showed a darker staining with methylene blue than normal crypts, often with oval or slit-like 1 lumens and a thicker epithelial lining (15) ( Figure 1 ).
2

Statistical analysis
3 Data were expressed as the mean ± SD for continuous variables and as a proportion 4 (%) for categorical variables. The prevalences of ACF among the normal subjects, 5 adenoma cases, and CRC cases were compared using age-and sex-adjusted logistic 6 regression analyses. The numbers of ACF among these three groups were also 7 compared using the Kruskal Wallis test or an age-and sex-adjusted linear regression 8 analysis. The chi-squared test and the Mann-Whitney U test were used to investigate the 9 association between the presence of ACF and the adenoma status as well as the 10 association between the presence of ACF and the location of adenoma(s)/CRC. In 11 addition, univariate and multivariate logistic regression analyses were used to identify 12 variables with significant independent effects on the prevalence of ACF among normal 13 subjects. Univariate and multivariate linear regression analyses were also performed to 14 identify significant variables influencing the number of ACF. The variables entered in 15 the model included age, sex, smoking habit, alcohol habit and BMI. Unless otherwise 16 specified, a P value < 0.05 was considered statistically significant. All the analyses were 17 performed using the SPSS statistical package (version 11.0 for Mac OS X). visualized endoscopically in 861 subjects: 1382 in normal subjects, 2288 in the 8 adenoma cases, and 1072 in the CRC cases. The prevalence of ACF was 64%, 88% and 9 95% for the normal subjects, adenoma cases, and CRC cases, respectively. The mean 10 number of ACF was 3.6 ± 5.2, 6.2 ± 7.0 and 10.1 ± 7.9 in the normal subjects, adenoma 11 cases, and CRC cases, respectively. the three subject groups stratified according to sex showed that the differences of the 1 prevalence of ACF among the three subject groups (normal subjects, adenoma cases, 2 and CRC cases) were significant (P<0.001 and P<0.001 for men and women, 3 respectively). In addition, an age-adjusted linear regression analysis for the three subject 4 groups stratified according to sex showed that the differences of the number of ACF 5 among the three subject groups (normal subjects, adenoma cases, and CRC cases) were 6 significant (P<0.001 and P<0.001 for men and women, respectively). The relationship between the presence of ACF and the adenoma history is shown in 10 Table 3 . The prevalence of ACF in subjects with advanced adenoma(s) did not differ 11 significantly from that of subjects with non-advanced adenoma(s) (89% and 87%, the proximal colon. No significant differences were observed between the prevalence 1 and number of ACF and the location of the adenoma(s) (P=0.86 and P=0.73, 2 respectively). Twenty-nine of the 102 CRC cases (28%) had proximal CRC. No 3 significant differences were observed between the prevalence and number of ACF and 4 the location of the CRC (P=0.52 and P=0.26, respectively). To investigate the risk factors for the prevalence of ACF, univariate and multivariate 8 logistic regression analyses were performed in normal subjects (Table 5 ). We defined 9 smoking habit as positive for subjects with more than 10-pack years who were still 10 smoking or who had quit within the past 10 years; alcohol habit was defined as positive 11 for subjects with alcohol consumption in excess of 45 g/day. Both of these factors are 12 reported to associate with an increased risk of adenoma and CRC (23-28). Age-and 13 sex-adjusted multivariate analyses revealed that smoking habit (odds ratio [OR], 1.6; 14 95% confidence interval [CI], 0.9-3.1) and alcohol habit (OR, 2.0; 95% CI, 0.8-5.0) 15 were not independent risk factor for the prevalence of ACF (P=0.12 and P=0.15, 16 respectively); however these two factors (OR, 5.4; 95% CI, 2.3-13.0) synergistically 17 increased the prevalence of ACF (P<0.001). Obesity was also reported to associate with Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
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Differences in the presence of ACF between subjects with non-advanced and
5
Correlations between the presence of ACF and demographic and behavioral
Author Manuscript Published OnlineFirst on July 12, 2011; DOI: 10.1158/1055-9965.EPI-11-0104 an increased risk of adenoma and CRC (28). We defined obesity as positive for subjects 1 with a BMI ≥ 25. Obesity (OR, 1.5; 95% CI, 0.8-2.6) was also not an independent risk 2 factor for the prevalence of ACF (P=0.17). We also performed univariate and age-and In our study, significant stepwise increments in both the prevalence and the number 10 of ACF were observed from normal subjects to adenoma cases to CRC cases. In 11 addition, the mean number of ACF was significantly higher in the subject group with 12 advanced adenoma than in the subject group with non-advanced adenoma. These results Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on July 12, 2011; DOI: 10.1158/1055-9965.EPI-11-0104 30). Tobacco contains a large number of carcinogens that may bind to DNA and form 1 adducts, potentially causing irreversible genetic damage to the normal colonic mucosa 2 (31). On the other hand, alcohol is metabolized to acetaldehyde, which binds to DNA 3 and forms carcinogenic adducts (32). Therefore these two factors may share a common 4 pathway in promoting colorectal carcinogenesis at an early stage and initiating ACF 5 formation. On the other hand, obesity was not strongly associated with the prevalence 6 of ACF because only a few patients were regarded as obese in our study. In contrast to 7 our hypothesis, no significant associations were observed between the number of ACF 8 and these factors, although smoking and alcohol habits tended to increase the number 9 of ACF in a synergistic manner. A not insignificant number of subjects exhibited an 10 extremely high density of ACF (as high as 30), even in normal subjects; therefore, the 11 wide variance in the number of ACF might have extinguished the statistical 12 significance ( Supplementary Figure 1) .
13
Although most previous epidemiological studies of ACF have shown a significant Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on July 12, 2011; DOI: 10.1158/1055-9965.EPI-11-0104 subject group based on the results of flexible sigmoidoscopy; thus, proximal adenomas pathway through the activation of AMPK, suppresses cellular proliferation and ACF 1 formation (35). These results suggested that ACF may be a marker for epithelial 2 proliferation. Importantly, previous studies have demonstrated that a high proliferative 3 activity in the colon mucosa is associated with an increased risk of CRC (37).
4
In conclusion, we confirmed that the prevalence and mean number of ACF 5 significantly increased with the stage of the adenoma-carcinoma sequence using age-6 and sex-adjusted analyses of a relatively large sample. We also showed that smoking 7 and alcohol habits synergistically increased the prevalence of ACF as well as the risk of 
